EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug
08/05/2025 14:37
May 8 (Reuters) - The European drugs regulator said on Thursday its safety committee has confirmed suicidal thoughts as a side effect of Organon's OGN.N anti hair-loss drug finasteride, following an EU-wide review of available data. (Reporting by Sneha S K; Editing by Shinjini Ganguli) ((Sneha.SK@thomsonreuters.com;))
Recent news on Organon & Co.
See all newsIndia's Sun Pharma misses debt fundraise goal as investors demand higher yields, bankers say
Brief: Organon & Co Says It Does Not Expect To Record Milestone Expense In Q3 2026
India's Persistent Systems plans debut rupee debt sale to fund acquisition, bankers say
India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
Organon & Co reports results for the quarter ended June 30 - Earnings Summary